(EQH) Axa Equitable Holdings - Ratings and Ratios
Variable Annuities, Life Insurance, Investment Management, Retirement Plans
Dividends
| Dividend Yield | 2.29% |
| Yield on Cost 5y | 4.48% |
| Yield CAGR 5y | 9.24% |
| Payout Consistency | 100.0% |
| Payout Ratio | 19.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.3% |
| Value at Risk 5%th | 49.0% |
| Relative Tail Risk | 1.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -20.21 |
| CAGR/Max DD | 0.62 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.390 |
| Beta | 1.349 |
| Beta Downside | 1.610 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.15% |
| Mean DD | 7.83% |
| Median DD | 5.34% |
Description: EQH Axa Equitable Holdings October 30, 2025
Equitable Holdings (EQH) is a diversified financial-services firm operating worldwide through six segments: Individual Retirement (variable annuities for affluent clients), Group Retirement (tax-deferred plans for schools, municipalities and SMBs), Asset Management (institutional, retail and private-wealth investment services), Protection Solutions (life, disability and supplemental employee benefits), Wealth Management (advisory, planning and insurance products), and Legacy (fixed-rate GMxB business with return-of-premium death benefits). The company, founded in 1859 and headquartered in New York, rebranded from AXA Equitable in January 2020.
In FY 2023 EQH reported revenue of roughly $6.2 billion, net income of $1.1 billion and an ROE near 12 %, supported by $1.3 trillion in assets under management and $380 billion in annuity and insurance reserves. The firm’s earnings are sensitive to interest-rate movements because higher rates improve the spread on guaranteed annuity products while also influencing demand for retirement savings.
Key macro drivers for EQH include the aging U.S. population, which is expanding the market for retirement and longevity solutions, and the ongoing shift toward defined-contribution plans that increase reliance on individual-choice investment platforms. Additionally, the recent Fed rate hikes are expected to enhance margins on fixed-income and guaranteed-benefit offerings, but may also pressure demand for new annuity purchases.
If you want a data-rich, side-by-side comparison of EQH’s valuation and risk metrics versus its peers, ValueRay’s platform provides the tools to dig deeper.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-696.0m TTM) > 0 and > 6% of Revenue (6% = 720.5m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 0.02pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1072 % (prev -74.68%; Δ 1147 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 1.25b > Net Income -696.0m (YES >=105%, WARN >=100%) |
| Net Debt (-7.24b) to EBITDA (761.0m) ratio: -9.52 <= 3.0 (WARN <= 3.5) |
| Current Ratio 95.18 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (303.2m) change vs 12m ago -4.71% (target <= -2.0% for YES) |
| Gross Margin 57.30% (prev 41.17%; Δ 16.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 3.92% (prev 3.67%; Δ 0.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.48 (EBITDA TTM 761.0m / Interest Expense TTM 229.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.78
| (A) 0.41 = (Total Current Assets 130.11b - Total Current Liabilities 1.37b) / Total Assets 314.41b |
| (B) 0.03 = Retained Earnings (Balance) 8.36b / Total Assets 314.41b |
| (C) -0.00 = EBIT TTM -111.0m / Avg Total Assets 306.70b |
| (D) 0.01 = Book Value of Equity 2.17b / Total Liabilities 312.46b |
| Total Rating: 2.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 32.89
| 1. Piotroski 3.0pt |
| 2. FCF Yield -5.09% |
| 3. FCF Margin 9.78% |
| 4. Debt/Equity 42.99 |
| 5. Debt/Ebitda -9.52 |
| 6. ROIC - WACC (= -9.32)% |
| 7. RoE -52.70% |
| 8. Rev. Trend -22.68% |
| 9. EPS Trend 16.78% |
What is the price of EQH shares?
Over the past week, the price has changed by -1.80%, over one month by +2.00%, over three months by -13.57% and over the past year by -1.89%.
Is EQH a buy, sell or hold?
- Strong Buy: 6
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EQH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64.2 | 40% |
| Analysts Target Price | 64.2 | 40% |
| ValueRay Target Price | 48.5 | 5.8% |
EQH Fundamental Data Overview November 25, 2025
P/E Forward = 5.3677
P/S = 1.1056
P/B = 164.1395
Beta = 1.111
Revenue TTM = 12.01b USD
EBIT TTM = -111.0m USD
EBITDA TTM = 761.0m USD
Long Term Debt = 6.36b USD (from longTermDebt, last quarter)
Short Term Debt = 238.0m USD (from shortTermDebt, last fiscal year)
Debt = 6.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -7.24b USD (from netDebt column, last quarter)
Enterprise Value = -23.06b USD (13.52b + Debt 6.36b - CCE 42.94b)
Interest Coverage Ratio = -0.48 (Ebit TTM -111.0m / Interest Expense TTM 229.0m)
FCF Yield = -5.09% (FCF TTM 1.18b / Enterprise Value -23.06b)
FCF Margin = 9.78% (FCF TTM 1.18b / Revenue TTM 12.01b)
Net Margin = -5.80% (Net Income TTM -696.0m / Revenue TTM 12.01b)
Gross Margin = 57.30% ((Revenue TTM 12.01b - Cost of Revenue TTM 5.13b) / Revenue TTM)
Gross Margin QoQ = -16.97% (prev 30.36%)
Tobins Q-Ratio = -0.07 (set to none) (Enterprise Value -23.06b / Total Assets 314.41b)
Interest Expense / Debt = 0.96% (Interest Expense 61.0m / Debt 6.36b)
Taxrate = 9.87% (-133.0m / -1.35b)
NOPAT = -100.0m (EBIT -111.0m * (1 - 9.87%)) [loss with tax shield]
Current Ratio = 95.18 (Total Current Assets 130.11b / Total Current Liabilities 1.37b)
Debt / Equity = 42.99 (Debt 6.36b / totalStockholderEquity, last quarter 148.0m)
Debt / EBITDA = -9.52 (Net Debt -7.24b / EBITDA 761.0m)
Debt / FCF = -6.16 (Net Debt -7.24b / FCF TTM 1.18b)
Total Stockholder Equity = 1.32b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.22% (Net Income -696.0m / Total Assets 314.41b)
RoE = -52.70% (Net Income TTM -696.0m / Total Stockholder Equity 1.32b)
RoCE = -1.44% (EBIT -111.0m / Capital Employed (Equity 1.32b + L.T.Debt 6.36b))
RoIC = -1.57% (negative operating profit) (NOPAT -100.0m / Invested Capital 6.38b)
WACC = 7.75% (E(13.52b)/V(19.88b) * Re(10.99%) + D(6.36b)/V(19.88b) * Rd(0.96%) * (1-Tc(0.10)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.18%
[DCF Debug] Terminal Value 58.44% ; FCFE base≈1.13b ; Y1≈739.1m ; Y5≈338.0m
Fair Price DCF = 15.45 (DCF Value 4.43b / Shares Outstanding 286.5m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 16.78 | EPS CAGR: -1.05% | SUE: -1.58 | # QB: 0
Revenue Correlation: -22.68 | Revenue CAGR: -19.81% | SUE: -0.52 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.85 | Chg30d=-0.020 | Revisions Net=-4 | Analysts=8
EPS next Year (2026-12-31): EPS=7.94 | Chg30d=-0.113 | Revisions Net=-4 | Growth EPS=+40.2% | Growth Revenue=+7.2%
Additional Sources for EQH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle